EcoDrugPlus

Ensembl ID : ENSDLAG00005015263
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSDLAG00005016029
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSDLAG00005021343
Gene Symbol: -
Cross references: -
259 Possible Orthologues:

Ensembl ID : ENSDLAG00005021431
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSDLAG00005022206
Gene Symbol: -
Cross references: -
249 Possible Orthologues:

Ensembl ID : ENSDLAG00005022275
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSDLAG00005022298
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSDLAG00005022258
Gene Symbol: -
Cross references: -
175 Possible Orthologues:

Ensembl ID : ENSDLAG00005000729
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSDLAG00005001576
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSDLAG00005000698
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSDLAG00005009568
Gene Symbol: -
Cross references: -
161 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).